Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Ocugen
OCGN
$410M
| $1.67M | ﹤0.01% |
1,286,888
+84,646
| +7% | +$132K |
|
2327
MACOM Technology Solutions
MTSI
$23.1B
| $1.67M | ﹤0.01% |
26,536
+11,652
| +78% | +$728K |
|
2328
A10 Networks
ATEN
$2.02B
| $1.67M | ﹤0.01% |
100,486
-34,486
| -26% | -$591K |
|
|
SI
2329
DELISTED
Silvergate Capital Corporation
SI
| $1.67M | ﹤0.01% |
96,022
+59,828
| +165% | +$2.37M |
|
|
VIVO
2330
DELISTED
Meridian Bioscience Inc
VIVO
| $1.67M | ﹤0.01% |
50,293
+20,319
| +68% | +$654K |
|
2331
Zai Lab
ZLAB
$2.36B
| $1.67M | ﹤0.01% |
54,400
-93,632
| -63% | -$2.95M |
|
|
MORF
2332
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.67M | ﹤0.01% |
62,428
+3,260
| +6% | +$89.1K |
|
2333
Quad
QUAD
$519M
| $1.67M | ﹤0.01% |
408,708
+107,968
| +36% | +$343K |
|
2334
Nelnet
NNI
$4.81B
| $1.67M | ﹤0.01% |
18,350
+2,301
| +14% | +$209K |
|
2335
Genmab
GMAB
$18B
| $1.66M | ﹤0.01% |
39,105
+100
| +0.3% | +$4.12K |
|
|
UNVR
2336
DELISTED
Univar Solutions Inc.
UNVR
| $1.66M | ﹤0.01% |
52,070
-6,984
| -12% | -$200K |
|
2337
American States Water
AWR
$3.36B
| $1.65M | ﹤0.01% |
17,865
+5,191
| +41% | +$473K |
|
2338
Pan American Silver
PAAS
$20.2B
| $1.65M | ﹤0.01% |
101,169
-40,597
| -29% | -$649K |
|
2339
CALL
T-Mobile US
TMUS
$192B
| $1.65M | ﹤0.01% |
+11,800
| New | +$1.7M |
|
2340
Mueller Industries
MLI
$15.3B
| $1.65M | ﹤0.01% |
111,720
+37,920
| +51% | +$605K |
|
2341
CALL
Take-Two Interactive
TTWO
$42.7B
| $1.65M | ﹤0.01% |
+15,820
| New | +$1.71M |
|
2342
Rayonier
RYN
$6.44B
| $1.64M | ﹤0.01% |
54,861
+19,905
| +57% | +$612K |
|
|
ELAT
2343
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $1.64M | ﹤0.01% |
83,979
+1,234
| +1% | +$24.8K |
|
2344
Cirrus Logic
CRUS
$6.23B
| $1.64M | ﹤0.01% |
22,007
-3,792
| -15% | -$273K |
|
|
DQ
2345
Daqo New Energy
DQ
$916M
| $1.64M | ﹤0.01% |
42,450
-14,800
| -26% | -$725K |
|
|
EQRX
2346
DELISTED
EQRx, Inc. Common Stock
EQRX
| $1.64M | ﹤0.01% |
665,179
+295,591
| +80% | +$1.16M |
|
2347
Blackstone Mortgage Trust
BXMT
$2.36B
| $1.63M | ﹤0.01% |
77,169
+12,171
| +19% | +$288K |
|
2348
Korn Ferry
KFY
$4.18B
| $1.63M | ﹤0.01% |
32,270
+4,099
| +15% | +$218K |
|
2349
Onto Innovation
ONTO
$13.5B
| $1.63M | ﹤0.01% |
23,966
+2,067
| +9% | +$148K |
|
2350
Brink's
BCO
$4.6B
| $1.63M | ﹤0.01% |
30,325
+12,792
| +73% | +$741K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.